Latest News about GSK
Recent news which mentions GSK
From Motley Fool
Exxon Mobil as COP26 play? Here’s why Morgan Stanley says some of the dirtiest companies will benefit from decarbonization.
November 01, 2021
From MarketWatch
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
These 3 Unique Stocks Have Undeniable Long-Term Upside
October 29, 2021
From Motley Fool
Shell stock tumbles after disappointing results as activist investor Third Point calls for a breakup
October 28, 2021
From MarketWatch
From Benzinga
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript
October 27, 2021
Tickers
GSK
From Motley Fool
GlaxoSmithKline Drops Research On Otilimab In COVID-19
October 27, 2021
From Benzinga
Glaxo Reports Double-Digit Growth In Q3 Pharma, Vaccine Sales, Updates FY21 Guidance
October 27, 2021
Tickers
GSK
From Benzinga
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
From Motley Fool
Earnings Scheduled For October 27, 2021
October 27, 2021
From Benzinga
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
From Benzinga
Investing $100,000 in These 3 Dividend Stocks Could Give You Annual Income of $7,700
October 24, 2021
From Motley Fool
From Motley Fool
Why 23andMe Stock Has Jumped 16% So Far This Week
October 21, 2021
From Motley Fool
From Motley Fool
Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
October 17, 2021
From Motley Fool
23andMe Stock Could Be a Big Winner If This 1 Thing Happens
October 17, 2021
From Motley Fool
3 Top Stocks You Can Still Buy for Under $20 a Share
October 15, 2021
From Motley Fool
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
October 13, 2021
From Motley Fool
Why CureVac Stock Is Tumbling Today
October 12, 2021
From Motley Fool
From MarketWatch
Winners and Losers of Rising Energy Prices
October 12, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
2 Stocks Set to Win From the Historic Malaria Vaccine Approval
October 12, 2021
From Motley Fool
Why Did Ocugen Stock Skyrocket On Monday?
October 12, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
Here's Why 2022 Could Be a Huge Year for GlaxoSmithKline
October 11, 2021
From Motley Fool
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
